US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

CRO Concept

1,258.11

+19.871.60%

Number of Gainers:2

Number of Losers:- -

Number of Flat:1

PE:- -

High:1,283.22

Open:1,264.91

Low:1,253.74

Close:1,238.25

Loading ...

Charles River Laboratories International, Inc. (CRL): Among the Worst Performing Stocks in S&P 500 So Far in 2025

LIVE MARKETS-Gauging the seat grab in index musical chairs

Sage Therapeutics Announces First Quarter 2025 Financial Results and Highlights Pipeline and Business Updates

Charles River Announces Inaugural Advanced Therapy Incubator Program Cohort

THOMSON REUTERS

Charles River Announces Inaugural Advanced Therapy Incubator Program Cohort

IQVIA celebrates Marie E. Lamont and Dr. Joanne Hackett, winners of Healthcare Businesswomen's Association Awards

3 Cash-Producing Stocks That Concern Us

Upslope Capital Management Sold Charles River (CRL) Due to Thesis Break

Press Release: IQVIA to Announce First-Quarter 2025 Results on May 6, 2025

Regeneron CRL for Eylea extension not surprising, says Oppenheimer

Charles River Laboratories International Inc : Jefferies Cuts Target Price to $100 From $169

THOMSON REUTERS

Regeneron Provides Update on EYLEA HD® (aflibercept) Injection 8 mg Supplemental Biologics License Application

Charles River Laboratories International, Inc. (CRL): Among Mid-Cap Stocks Insiders Were Buying in Q1 2025

Charles River price target raised to $118 from $101 at Baird

Charles River Laboratories International Inc : Baird Raises Target Price to $118 From $101

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4530/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4530","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4530\",,,,,undefined,":{"symbol":"BK4530","market":"US","secType":"PLATE","nameCN":"CRO Concept","latestPrice":1258.114,"timestamp":1746215999999,"preClose":1238.2478,"halted":0,"volume":2635459,"delay":0,"changeRate":0.016044,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":19.866211,"latestTime":"05-02 16:00:00 EDT","open":1264.9078,"high":1283.2225,"low":1253.7415,"amount":372685197.227501,"amplitude":0.023809,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1746432000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.398471,"peRate":23.209768,"turnoverRate":0.011982,"increases":2,"decrements":0,"flats":0,"marketCap":32879079424,"floatMarketCap":32056822784},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4530\",,,,,undefined,":{"symbol":"BK4530","high":1283.2225,"amplitude":0.023809,"preClose":1238.2478,"low":1253.7415,"pbRate":"3.398471","latestPrice":1258.114,"volume":2635459,"delay":0,"open":1264.9078,"prevYearClose":1673.3123,"prevWeekClose":1229.9082,"prevMonthClose":1268.6176,"prevQuarterClose":1472.5228,"fiveDayClose":1229.9082,"twentyDayClose":1395.9784,"sixtyDayClose":1696.1396,"secType":"PLATE","market":"US","turnoverRate":0.011982,"peRate":23.209768,"marketCap":32879079424,"floatMarketCap":32056822784,"timestamp":1746215999999,"nameCN":"CRO Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4530\",,,,undefined,":{"bkCode":"BK4530","up":2,"down":0,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4530\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2532432016","title":"Charles River Laboratories International, Inc. (CRL): Among the Worst Performing Stocks in S&P 500 So Far in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2532432016","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532432016?lang=en_us&edition=fundamental","pubTime":"2025-05-01 07:39","pubTimestamp":1746056396,"startTime":"0","endTime":"0","summary":"We recently published a list of the 11 Worst Performing Stocks in S&P 500 So Far in 2025. In this article, we will take a look at where Charles River Laboratories International, Inc.  stands against other worst performing stocks this year.After a two-year surge of 53%, marking the best performance for the broad market index since the 1997-98 rally, stocks have been taken for a wild ride in 2025 due to uncertainties around recent tariffs, resulting in a year-to-date decline of nearly 6%.READ ALSO:11 Most Promising Stocks According to Analystsand15 Best Dividend Stocks to Buy for Long-Term Passive Income.Trends over the past century have shown that sustained high returns are uncommon. Following the strong back-to-back performance in the 1920s, markets fell sharply in 1929, which marked the beginning of the Great Depression. Then, after recovering in 1935 and 1936, it took a giant step back again a year later.For this article, we went through screeners to identify stocks listed on the S&P","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/charles-river-laboratories-international-inc-233956492.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CRL","BK4585","LU0757428866.USD","LU0390134368.USD","BK4530","LU1815336091.USD",".SPX","BK4588","VOO","BK4121","SPY"],"gpt_icon":0},{"id":"2531050854","title":"LIVE MARKETS-Gauging the seat grab in index musical chairs","url":"https://stock-news.laohu8.com/highlight/detail?id=2531050854","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531050854?lang=en_us&edition=fundamental","pubTime":"2025-04-30 23:52","pubTimestamp":1746028330,"startTime":"0","endTime":"0","summary":"CLICK HEREWALL STREET DIPS AS U.S. ECONOMY CONTRACTS CLICK HEREBENCHMARK TREASURY YIELD TRYING TO SNAP 6-DAY STREAK OF DECLINES CLICK HERECTAS: A TURNAROUND IN SIGHT?CLICK HEREWHAT TO OWN IN A FRAGMENTED WORLD CLICK HEREEUROPEAN E","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250430:nL1N3R810I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1201861249.SGD","VEEV","LU2087625088.SGD","LU0390134368.USD","LU2449327464.USD","TW","XYZ","IE00B3QW5Z07.USD","DFS","LU1559883803.SGD","LU2361045086.USD","ASL.UK","LU1363072403.SGD","LU1791807156.HKD","LU1861220207.SGD","COF","LU0122376428.USD","LNG","LU1670628061.USD","LU2461242641.AUD","LSEG.UK","HSL.UK","ARES","LPLA","CORT","THRG.UK","MKL","LU1720051108.HKD","BK4107","LU1019634622.SGD","LU2271345857.HKD","LU0057025933.USD","LU0171280430.USD","LU0048573561.USD","OWL","CRL","FLUT","LU0266013472.USD","LU0251142724.SGD","LU0887340254.USD","BK5051","TTD","CVNA","BK4121","LU2211817866.USD","BK4530","IE00B29SXL02.USD","LU1804176565.USD"],"gpt_icon":1},{"id":"2531794241","title":"Sage Therapeutics Announces First Quarter 2025 Financial Results and Highlights Pipeline and Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2531794241","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531794241?lang=en_us&edition=fundamental","pubTime":"2025-04-30 04:05","pubTimestamp":1745957100,"startTime":"0","endTime":"0","summary":"Achieved $13.8 million in ZURZUVAE  collaboration revenue in the first quarter of 2025 , representing a 21% increase from the fourth quarter. Sustained growth in shipments to women with postpartum depression; Greater than 3,000 shipments in first quarter of 2025 . Cash, cash equivalents, and marketable securities of $424 million as of March 31, 2025; Cash runway expected to support operations to mid-2027. CAMBRIDGE, Mass., April 29, 2025----Sage Therapeutics, Inc. , today reported business highlights and financial results for the first quarter ended March 31, 2025.\"We delivered strong growth in revenue and shipments of ZURZUVAE during the first quarter of 2025 through the team’s disciplined execution and unwavering commitment to bringing ZURZUVAE to more women with postpartum depression,\" said Barry Greene, Chief Executive Officer at Sage Therapeutics. \"We remain focused on establishing ZURZUVAE as the standard of care for women with postpartum depression and driving our business strat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sage-therapeutics-announces-first-quarter-200500915.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4081","PPD","BK4139","BK4121","GABA","BK4211","BK4563","BK4135","BK4561","CNS","SAGE","BK4530","PAM"],"gpt_icon":0},{"id":"2531874717","title":"Charles River Announces Inaugural Advanced Therapy Incubator Program Cohort","url":"https://stock-news.laohu8.com/highlight/detail?id=2531874717","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531874717?lang=en_us&edition=fundamental","pubTime":"2025-04-29 20:00","pubTimestamp":1745928003,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nTUAC2LMDT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4530","LU0757428866.USD","BK4588","LU0390134368.USD","BK4585","LU1815336091.USD","CRL","BK4121"],"gpt_icon":0},{"id":"2531736385","title":"Charles River Announces Inaugural Advanced Therapy Incubator Program Cohort","url":"https://stock-news.laohu8.com/highlight/detail?id=2531736385","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531736385?lang=en_us&edition=fundamental","pubTime":"2025-04-29 20:00","pubTimestamp":1745928000,"startTime":"0","endTime":"0","summary":"WILMINGTON, Mass., April 29, 2025----Charles River Laboratories International, Inc.  today announced the initial cohort of its Charles River Incubator Program . Launched in December 2024, the program offers early-stage biotechnology pioneers access to extensive scientific and commercial expertise and a wide ecosystem of discovery, development, and manufacturing capabilities to expedite the development of technologies and life-changing therapies for patients in need.The first cohort includes six advanced therapy and technology developers: 64x Bio, Adjuva Bio, Purilogics by Donaldson, Gordian Bio, NanoPalm, and NVI Therapeutics. Participants will benefit from tailored mentorship, consultative regulatory and quality expertise, fit-for-purpose training initiatives, and preferential access to Charles River’s global network of facilities.NanoPalm: Developing in vivo therapies for genetic diseases with an advanced lipid nanoparticle  manufacturing process designed by NanoPalm’s artificial int","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/charles-river-announces-inaugural-advanced-120000666.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4121","IE0031619046.USD","LU0390134368.USD","LU1815336091.USD","BK4157","BK4585","IE00B19Z4B17.USD","AEIS","CRL","IE00B66KJ199.SGD","LU0757428866.USD","BK4588","BK4530","IE00B7SZL793.SGD"],"gpt_icon":0},{"id":"2530428348","title":"IQVIA celebrates Marie E. Lamont and Dr. Joanne Hackett, winners of Healthcare Businesswomen's Association Awards","url":"https://stock-news.laohu8.com/highlight/detail?id=2530428348","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530428348?lang=en_us&edition=fundamental","pubTime":"2025-04-28 21:00","pubTimestamp":1745845200,"startTime":"0","endTime":"0","summary":"RESEARCH TRIANGLE PARK, N.C., April 28, 2025----IQVIA , a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, announced today that Marie E. Lamont, head of Real World Solutions , and Dr. Joanne Hackett, vice president, Health System Services , have been honored by the Healthcare Businesswomen’s Association . Marie has been named a Luminary, and Joanne has been recognized as a Rising Star.Marie was honored for her significant contributions to IQVIA including increasing the patient voice in research and care delivery combined with her dedication to advancing women in the healthcare industry. She joined IQVIA through the 2021 acquisition of Inteliquet and quickly integrated her team into the larger organization, earning the trust of executives. Marie's strategic leadership of nearly 800 colleagues across the U.S., India and Europe has significantly improved operational performance. She serve","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/iqvia-celebrates-marie-e-lamont-130000698.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4137","BK4134","LU0130518102.USD","BK4585","LU1791710400.SGD","LU0980610538.SGD","LU1989764748.USD","LU1989764664.SGD","LU0477156797.USD","LU0648001328.SGD","BK4530","LU1201861249.SGD","LU0528227936.USD","BK4121","LU0130517989.USD","LU1201861165.SGD","LU1791710582.SGD","LU0648000940.SGD","LU0477156953.USD","LU1261432733.SGD","BK4588","LU0130103400.USD","LU0882574055.USD","HCKT","HCSG","LU0130102774.USD","LU0198837287.USD","IQV"],"gpt_icon":0},{"id":"2529802626","title":"3 Cash-Producing Stocks That Concern Us","url":"https://stock-news.laohu8.com/highlight/detail?id=2529802626","media":"StockStory","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529802626?lang=en_us&edition=fundamental","pubTime":"2025-04-23 21:01","pubTimestamp":1745413317,"startTime":"0","endTime":"0","summary":"Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.Luckily for you, we built StockStory to help you separate the good from the bad. That said, here are three cash-producing companies that don’t make the cut and some better opportunities instead.Created by IAC’s mergers of Angie’s List and HomeAdvisor, ANGI  operates the largest online marketplace for home services in the US.Struggled with new customer acquisition as its service requests averaged 23.3% declines. Sales are projected to tank by 13% over the next 12 months as its demand continues evaporating. Highly competitive market means it’s on the never-ending treadmill of sales and marketing spend. At $12.50 per share, Angi trades at 47.7x forward EV-to-EBITDA. Dive into our free research report to see why there are better opportunities than ANGI.Negative earnings profile makes it challen","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-cash-producing-stocks-concern-130157329.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1815336091.USD","BK4530","BK4129","BK4588","BK4585","TPC","LU0390134368.USD","BK4077","LU0757428866.USD","BK4121","ANGI","CRL"],"gpt_icon":0},{"id":"2529475582","title":"Upslope Capital Management Sold Charles River (CRL) Due to Thesis Break","url":"https://stock-news.laohu8.com/highlight/detail?id=2529475582","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529475582?lang=en_us&edition=fundamental","pubTime":"2025-04-22 22:01","pubTimestamp":1745330518,"startTime":"0","endTime":"0","summary":"Upslope Capital Management, an investment management firm, released its first-quarter 2025 investor letter. A copy of the letter can be downloaded here. The First quarter was challenging for the fund. However, the world has transformed in the two weeks since March 31, due to a drastic realignment of international trade rules. As a result, markets are now more in line with Upslope's strategy and portfolio. The fund returned -5.1%  in Q1 compared to -6.1% and +0.2% for the S&P Midcap 400 ETF  and HFRX Equity Hedge Index, respectively. In addition, you can check the fund’s top 5 holdings to determine its best picks for 2025.Upslope Capital Management stated the following regarding Charles River Laboratories International, Inc.  in its Q1 2025 investor letter:. In another article, we covered Charles River Laboratories International","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/upslope-capital-management-sold-charles-140158787.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CRL","BK4530","LU0390134368.USD","LU1815336091.USD","BK4121","LU0757428866.USD","BK4585","BK4588","MDY"],"gpt_icon":0},{"id":"2529307633","title":"Press Release: IQVIA to Announce First-Quarter 2025 Results on May 6, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2529307633","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529307633?lang=en_us&edition=fundamental","pubTime":"2025-04-22 04:20","pubTimestamp":1745266800,"startTime":"0","endTime":"0","summary":"IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA's insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of dise","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0648000940.SGD","BK4099","LU0882574055.USD","BK4585","LU0477156797.USD","LU0528227936.USD","LU1201861249.SGD","LU0648001328.SGD","BK4530","LU0130103400.USD","IQV","LU1791710400.SGD","LU0130517989.USD","LU0198837287.USD","BK4555","LU1261432733.SGD","LU0130518102.USD","TM","LU1201861165.SGD","LU0130102774.USD","LU0477156953.USD","BK4604","LU1989764748.USD","LU1791710582.SGD","03160","LU0980610538.SGD","BK4121","BK4588","LU1989764664.SGD"],"gpt_icon":0},{"id":"2529471800","title":"Regeneron CRL for Eylea extension not surprising, says Oppenheimer","url":"https://stock-news.laohu8.com/highlight/detail?id=2529471800","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529471800?lang=en_us&edition=fundamental","pubTime":"2025-04-21 22:10","pubTimestamp":1745244617,"startTime":"0","endTime":"0","summary":"Oppenheimer keeps an Outperform rating on Regeneron (REGN) with a $925 price target after the FDA denied the company’s attempt to extend the dosing...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/regeneron-crl-for-eylea-extension-not-surprising-says-oppenheimer?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/regeneron-crl-for-eylea-extension-not-surprising-says-oppenheimer?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4127","LU0114720955.EUR","BK4530","LU0058720904.USD","LU1974910355.USD","LU1815336091.USD","REGN","LU0390134368.USD","BK4121","LU0109394709.USD","LU0289739699.SGD","CRL","BK4588","LU0757428866.USD","LU2106854487.HKD","LU2468319806.SGD","LU0320765992.SGD","BK4585","LU0053666078.USD","LU2362541513.USD","OPY","LU1917777945.USD","LU0889565916.HKD","LU2237438978.USD","BK4139","LU2362541273.HKD","LU0823416689.USD","LU2023250504.SGD","LU2089984988.USD","LU0882574055.USD","LU2362540622.SGD"],"gpt_icon":0},{"id":"2529845834","title":"Charles River Laboratories International Inc : Jefferies Cuts Target Price to $100 From $169","url":"https://stock-news.laohu8.com/highlight/detail?id=2529845834","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529845834?lang=en_us&edition=fundamental","pubTime":"2025-04-21 12:59","pubTimestamp":1745211591,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250421:nFWN3QZ041:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CRL","BK4585","LU0757428866.USD","LU0390134368.USD","BK4530","LU1815336091.USD","BK4588","BK4121"],"gpt_icon":0},{"id":"2528013715","title":"Regeneron Provides Update on EYLEA HD® (aflibercept) Injection 8 mg Supplemental Biologics License Application","url":"https://stock-news.laohu8.com/highlight/detail?id=2528013715","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528013715?lang=en_us&edition=fundamental","pubTime":"2025-04-19 03:00","pubTimestamp":1745002800,"startTime":"0","endTime":"0","summary":"TARRYTOWN, N.Y., April 18, 2025  -- Regeneron Pharmaceuticals, Inc.  today announced that the U.S. Food and Drug Administration  has issued a complete response letter  regarding the supplemental Biologics License Application  for the addition of extended dosing intervals  for EYLEA HD  Injection 8 mg across all approved indications.EYLEA HD is approved with dosing intervals from every 8 to 16 weeks for patients with wet age-related macular degeneration  and diabetic macular edema , and every 8 to 12 weeks for patients with diabetic retinopathy , following 3 initial monthly doses.About Ophthalmology Development at Regeneron At Regeneron, we relentlessly pursue groundbreaking innovations in eye care science to help maintain the eye health of the millions of Americans impacted by vision-threatening conditions. Our expertise in angiogenesis and decades of research serve as our foundation, fueling our ongoing ambition to further innovate new solutions for patients. Our robust and diverse re","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/regeneron-provides-eylea-hd-aflibercept-190000362.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1917777945.USD","BK4532","LU1951198990.SGD","LU1880398471.USD","LU0058720904.USD","IE00BKVL7J92.USD","LU1316542783.SGD","CRL","HD","LU0198837287.USD","LU0127658192.USD","REGN","LU0950375773.USD","IE00BMPRXR70.SGD","LU1929549753.HKD","IE0009356076.USD","LU1551013425.SGD","BK4581","LU0868494708.USD","LU1778281490.HKD","BK4575","LU0234572021.USD","BK4534","BK4206","LU0109392836.USD","LU1951200564.SGD","LU0354030438.USD","LU1988902786.USD","LU0079474960.USD","BK4612","IE00BQXX3F31.USD","LU0082616367.USD","LU0889565916.HKD","LU2458330169.SGD","LU1242518931.SGD","LU1430594728.SGD","BK4023","BK4530","LU2506951958.HKD","LU1303367103.USD","LU0823411888.USD","LU2098885051.SGD","LU2264538146.SGD","SG9999001440.SGD","BK4605","LU2468319806.SGD","ROP","BK4533","IE00BSNM7G36.USD"],"gpt_icon":1},{"id":"2528085255","title":"Charles River Laboratories International, Inc. (CRL): Among Mid-Cap Stocks Insiders Were Buying in Q1 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2528085255","media":"Insider Monkey","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528085255?lang=en_us&edition=fundamental","pubTime":"2025-04-18 11:01","pubTimestamp":1744945314,"startTime":"0","endTime":"0","summary":"We recently published a list of 20 Mid-Cap Stocks Insiders Were Buying in Q1 2025. In this article, we are going to take a look at where Charles River Laboratories International, Inc.  stands against other mid-cap stocks insiders were buying in Q1 2025.Stock markets tumbled on Wednesday, with technology shares leading the slide amid growing concerns over ever-changing tariffs. The broader market index dropped 2.2%, the blue-chip companies fell by almost 700 points, a decline of 1.7%, and the Nasdaq Composite —dominated by tech—plunged nearly 3.1%. With this decline, the Nasdaq is now about 19% below its recent peak, edging closer to bear market territory.Stocks dropped to their lowest levels of the day Wednesday after Fed Chair Jerome Powell warned that the tariffs could increase short-term inflation. He noted the Federal Reserve might face a tough situation where its goals of full employment and stable prices may come into conflict, according to CNBC.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/charles-river-laboratories-international-inc-030154003.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4530","US5Y.BOND","BK4079","US7Y.BOND","US3Y.BOND","LU0757428866.USD","BK4121","COMP","BK4588","CRL","US12M.BOND","BK4539","US2Y.BOND","LU0390134368.USD","US10Y.BOND","LU1815336091.USD","US30Y.BOND","BK4585","US6M.BOND"],"gpt_icon":0},{"id":"2528189597","title":"Charles River price target raised to $118 from $101 at Baird","url":"https://stock-news.laohu8.com/highlight/detail?id=2528189597","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528189597?lang=en_us&edition=fundamental","pubTime":"2025-04-17 19:15","pubTimestamp":1744888523,"startTime":"0","endTime":"0","summary":"Baird analyst Eric Coldwell raised the firm’s price target on Charles River (CRL) to $118 from $101 and keeps a Neutral rating on the shares. The f...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/charles-river-price-target-raised-to-118-from-101-at-baird?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/charles-river-price-target-raised-to-118-from-101-at-baird?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1815336091.USD","BK4530","BK4585","LU0390134368.USD","BK4588","LU0757428866.USD","BK4121","CRL"],"gpt_icon":0},{"id":"2528734072","title":"Charles River Laboratories International Inc : Baird Raises Target Price to $118 From $101","url":"https://stock-news.laohu8.com/highlight/detail?id=2528734072","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528734072?lang=en_us&edition=fundamental","pubTime":"2025-04-17 12:06","pubTimestamp":1744862766,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nFWN3QV024:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0390134368.USD","BK4530","BK4585","LU0757428866.USD","BK4121","CRL","LU1815336091.USD","BK4588"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":15,"code":"91000000","status":"200"}]}}